Domača stranTEVA • NYSE
add
Teva
17,12 $
Po zaprtju:(0,47 %)−0,080
17,04 $
Konec trgovanja: 22. nov., 17:05:00 GMT -5 · USD · NYSE · Izjava
Prejšnji trg. dan.
17,08 $
Dnevni razpon
16,86 $ - 17,13 $
Letni razpon
9,35 $ - 19,31 $
Tržna kapitalizacija
19,29 mrd. USD
Povprečni obseg
6,78 mio.
V novicah
Finančni podatki
Izkaz poslovnega izida
Prihodek
Čisti dohodek
| (USD) | sep. 2024info | Sprememba L/L |
|---|---|---|
Prihodek | 4,33 mrd. | 12,52 % |
Stroški poslovanja | 1,14 mrd. | 5,05 % |
Čisti dohodek | −437,00 mio. | −733,33 % |
Čista dobičkovnost prihodkov | −10,09 | −663,69 % |
Earnings per share | 0,69 | 15,00 % |
EBITDA | 1,26 mrd. | 20,98 % |
Efektivna davčna stopnja | −21,50 % | — |
Bilanca stanja
Skupna sredstva
Skupne obveznosti
| (USD) | sep. 2024info | Sprememba L/L |
|---|---|---|
Denar. in kratkor. naložbe | 3,32 mrd. | 47,58 % |
Skupna sredstva | 41,76 mrd. | −0,78 % |
Skupne obveznosti | 35,37 mrd. | 2,31 % |
Celoten lastniški kapital | 6,38 mrd. | — |
Shares outstanding | 1,13 mrd. | — |
Razmerje P/B | 3,19 | — |
Donosnost sredstev | 6,04 % | — |
Donosnost kapitala | 9,82 % | — |
Denarni tok
Neto sprememba denarnih sredstev
| (USD) | sep. 2024info | Sprememba L/L |
|---|---|---|
Čisti dohodek | −437,00 mio. | −733,33 % |
Denar iz dejavnosti | 693,00 mio. | 13.760,00 % |
Denar iz naložb | 268,00 mio. | 45,65 % |
Denar iz financiranja | — | — |
Neto sprememba denarnih sredstev | 1,06 mrd. | 352,62 % |
Prost denarni tok | 1,28 mrd. | 62,91 % |
Vizitka
Teva Pharmaceutical Industries Ltd. is an Israeli multinational pharmaceutical company. Teva specializes primarily in generic drugs, but other business interests include branded-drugs, active pharmaceutical ingredients and, to a lesser extent, contract manufacturing services and an out-licensing platform.
Teva's primary branded products include Austedo which is used for the treatment of chorea associated with Huntington's disease and tardive dyskinesia; and Ajovy, used for the preventive treatment of migraine in adults. Additional branded drugs sold by Teva include Copaxone, Bendeka and Treanda, all of which are primarily sold in the United States.
Teva is listed on the Tel Aviv Stock Exchange and the New York Stock Exchange. Its manufacturing facilities are located in Israel, North America, Europe, Australia, and South America. The company is a member of the Pharmaceutical Research and Manufacturers of America.
Teva Pharmaceuticals is the largest generic drug manufacturer in the world. Overall, Teva is the 18th largest pharmaceutical company in the world. Teva has a history of legal trouble in relation to collusion and price-fixing to inflate prices for drugs. Wikipedia
Generalni direktor
Datum ustanovitve
13. feb. 1944
Spletno mesto
Zaposleni
37.000
